Drug discovery is just one of the fields where AI has become indispensable in healthcare. Decentralized trials and personalized treatments hold promise of enormous breakthroughs as well. We asked Mark Lambrecht, Director of Global Health & Life Sciences Practice at SAS to take a snapshot of the state of play of AI in clinical research and to tell us what to expect down the road.

All AI Studio/MI Stúdió episodes and the latest on AI in Hungary and the CEE region are available at www.ai-hungary.com.

All rights reserved. This show is the property of Digitális Jólét Nonprofit Kft.

Music by: audionautix.com